JCXH-108

· Immorna Biotherapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JCXH-108, covering 2026-04-23 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Study to Evaluate JCXH-108, an mRNA-based Vaccine Against RSV [Phase 1]